Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HOMA Estimated Insulin Resistance as a Marker for Angiographic Severity of Coronary Artery Disease in Non Diabetic & Non Obese Patients.

NCT05215821 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT05215821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05215821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HOMA Estimated Insulin Resistance as a Marker for Angiographic Severity of Coronary Artery Disease in Non Diabetic & Non Obese Patients.
Lead sponsor
Sohag University
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2021
Completion date
February 28, 2022
Enrollment
112 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance